Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Blueprint Medicines to host conference call » 16:10
04/10/21
04/10
16:10
04/10/21
16:10
BPMC

Blueprint Medicines

$94.14 /

+0.25 (+0.27%)

Management reviews new…

Management reviews new data for multiple research and clinical-stage programs across the Company's precision oncology and hematology portfolio on a conference call to be held on April 12 at 8 am. Webcast Link

ShowHide Related Items >><<
BPMC Blueprint Medicines
$94.14 /

+0.25 (+0.27%)

BPMC Blueprint Medicines
$94.14 /

+0.25 (+0.27%)

04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
03/30/21 Credit Suisse
Blueprint Medicines initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Blueprint Medicines initiated with a Neutral at Credit Suisse
02/18/21 Barclays
Blueprint Medicines price target raised to $95 from $90 at Barclays
BPMC Blueprint Medicines
$94.14 /

+0.25 (+0.27%)

On The Fly
Opening Day: Phone maker UTime soars in public debut » 08:39
04/10/21
04/10
08:39
04/10/21
08:39
SVFD

Save Foods

/

+

, RGCB

Regencell Bioscience

/

+

, RPHM

Reneo Pharmaceuticals

$13.89 /

-1.64 (-10.56%)

, VECT

Vectivbio

$24.01 /

+1.11 (+4.85%)

, UTME

UTime

$48.63 /

+5.53 (+12.83%)

, COIN

Coinbase

/

+

, AGL

Agilon Health

/

+

, SWIM

Latham Group

$10.45 /

+ (+0.00%)

, EDR

Endeavor

$41.49 /

+ (+0.00%)

, UBER

Uber

$57.72 /

-0.11 (-0.19%)

, LYFT

Lyft

$60.96 /

-1.07 (-1.72%)

, PFE

Pfizer

$36.60 /

+0.64 (+1.78%)

, INTM

Intermedia Cloud

/

+

Shares of China-based…

ShowHide Related Items >><<
UTME UTime
$48.63 /

+5.53 (+12.83%)

UBER Uber
$57.72 /

-0.11 (-0.19%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LYFT Lyft
$60.96 /

-1.07 (-1.72%)

COIN Coinbase
/

+

SVFD Save Foods
/

+

RGCB Regencell Bioscience
/

+

RPHM Reneo Pharmaceuticals
$13.89 /

-1.64 (-10.56%)

VECT Vectivbio
$24.01 /

+1.11 (+4.85%)

UTME UTime
$48.63 /

+5.53 (+12.83%)

COIN Coinbase
/

+

04/07/21 JMP Securities
Coinbase report shows 'substantial business momentum,' says JMP Securities
03/03/21
Fly Intel: Top five analyst initiations
03/03/21 DA Davidson
Coinbase initiated with a Buy at DA Davidson
AGL Agilon Health
/

+

SWIM Latham Group
$10.45 /

+ (+0.00%)

EDR Endeavor
$41.49 /

+ (+0.00%)

UBER Uber
$57.72 /

-0.11 (-0.19%)

04/05/21 Evercore ISI
Uber assumed with an Outperform at Evercore ISI
04/01/21
Fly Intel: Top five analyst initiations
04/01/21 Jefferies
Uber initiated with a Buy at Jefferies
03/31/21 Wolfe Research
Uber assumed with an Outperform at Wolfe Research
LYFT Lyft
$60.96 /

-1.07 (-1.72%)

04/05/21 Evercore ISI
Lyft assumed with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Lyft assumed with a Peer Perform at Wolfe Research
03/26/21
Fly Intel: Top five analyst initiations
03/26/21 Vertical Research
Lyft initiated with a Buy at Vertical Research
PFE Pfizer
$36.60 /

+0.64 (+1.78%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
INTM Intermedia Cloud
/

+

UBER Uber
$57.72 /

-0.11 (-0.19%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LYFT Lyft
$60.96 /

-1.07 (-1.72%)

COIN Coinbase
/

+

  • 15
    Apr
  • 09
    Apr
  • 09
    Apr
  • 07
    Apr
  • 01
    Apr
  • 08
    Jan
UBER Uber
$57.72 /

-0.11 (-0.19%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LYFT Lyft
$60.96 /

-1.07 (-1.72%)

COIN Coinbase
/

+

UBER Uber
$57.72 /

-0.11 (-0.19%)

SVFD Save Foods
/

+

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LYFT Lyft
$60.96 /

-1.07 (-1.72%)

COIN Coinbase
/

+

UBER Uber
$57.72 /

-0.11 (-0.19%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LYFT Lyft
$60.96 /

-1.07 (-1.72%)

Conference/Events
American Association for Cancer Research to hold a virtual meeting » 04:55
04/10/21
04/10
04:55
04/10/21
04:55
MDGEF

MediGene

$4.80 /

+ (+0.00%)

, GLSI

Greenwich LifeSciences

$53.50 /

+4.21 (+8.54%)

, JNCE

Jounce Therapeutics

$9.76 /

-0.65 (-6.24%)

, ATNM

Actinium Pharmaceuticals

$8.10 /

-0.085 (-1.04%)

, BDTX

Black Diamond Therapeutics

$24.61 /

-0.31 (-1.24%)

, CRSP

Crispr Therapeutics

$115.49 /

-4.67 (-3.89%)

, HARP

Harpoon Therapeutics

$22.70 /

-0.03 (-0.13%)

, ITOS

iTeos Therapeutics

$26.99 /

-3.12 (-10.36%)

, REPL

Replimune Group

$30.04 /

-0.52 (-1.70%)

, RVMD

Revolution Medicines

$42.65 /

-2.46 (-5.45%)

, ZNTL

Zentalis

$37.35 /

-5.19 (-12.20%)

, IMCR

Immunocore

$35.01 /

-0.99 (-2.75%)

, PMVP

PMV Pharmaceuticals

$33.30 /

-0.605 (-1.78%)

, ARVN

Arvinas

$63.55 /

-0.83 (-1.29%)

, IOVA

Iovance Biotherapeutics

$30.17 /

-1.12 (-3.58%)

, ADXS

Advaxis

/

+

, AGEN

Agenus

$2.78 /

-0.01 (-0.36%)

, BPTH

Bio-Path

$6.79 /

-0.13 (-1.88%)

, INCY

Incyte

$79.97 /

-0.91 (-1.13%)

, IMAB

I-MAB

$51.50 /

-1.34 (-2.54%)

, MRSN

Mersana Therapeutics

$15.79 /

-0.27 (-1.68%)

, RUBY

Rubius Therapeutics

$23.92 /

-0.14 (-0.58%)

, PPBT

Purple Biotech

$4.31 /

+0.035 (+0.82%)

, SONN

Sonnet BioTherapeutics

$2.24 /

-0.05 (-2.18%)

, STTK

Shattuck Labs

$28.31 /

+1.365 (+5.07%)

, SURF

Surface Oncology

$7.93 /

-0.22 (-2.70%)

, BGNE

BeiGene

$308.27 /

-5.8 (-1.85%)

, CMPI

Checkmate Pharmaceuticals

$10.52 /

+0.14 (+1.35%)

, BNGO

Bionano Genomics

$7.29 /

-0.215 (-2.87%)

AACR Virtual Annual…

AACR Virtual Annual Meeting 2021 will be held on April 9-15. Webcast Link

ShowHide Related Items >><<
ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

SONN Sonnet BioTherapeutics
$2.24 /

-0.05 (-2.18%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

PPBT Purple Biotech
$4.31 /

+0.035 (+0.82%)

PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

IOVA Iovance Biotherapeutics
$30.17 /

-1.12 (-3.58%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

IMAB I-MAB
$51.50 /

-1.34 (-2.54%)

HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

CMPI Checkmate Pharmaceuticals
$10.52 /

+0.14 (+1.35%)

BPTH Bio-Path
$6.79 /

-0.13 (-1.88%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

BGNE BeiGene
$308.27 /

-5.8 (-1.85%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

ATNM Actinium Pharmaceuticals
$8.10 /

-0.085 (-1.04%)

ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

AGEN Agenus
$2.78 /

-0.01 (-0.36%)

ADXS Advaxis
/

+

MDGEF MediGene
$4.80 /

+ (+0.00%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
11/10/20 Roth Capital
Jounce Therapeutics price target lowered to $15 from $28 at Roth Capital
ATNM Actinium Pharmaceuticals
$8.10 /

-0.085 (-1.04%)

04/06/21 William Blair
Actinium's Q4 net loss roughly in line with projected loss, says William Blair
12/29/20 H.C. Wainwright
H.C. Wainwright keeps Buy on Actinium amid 'headline disappointment'
12/29/20 JonesTrading
Actinium selloff today 'clear buying opportunity,' says JonesTrading
11/05/20
Fly Intel: Top five analyst initiations
BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/04/21 JMP Securities
Crispr Therapeutics initiated with an Outperform at JMP Securities
03/01/21 Barclays
Crispr Therapeutics price target raised to $140 from $113 at Barclays
02/17/21 Goldman Sachs
Crispr Therapeutics price target lowered to $189 from $193 at Goldman Sachs
HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

03/11/21 Roth Capital
Harpoon's 2020/2021 should be 'festival of data,' says Roth Capital
01/04/21 Roth Capital
Harpoon having fourth candidate in clinic 'impressive,' says Roth Capital
12/23/20 H.C. Wainwright
Harpoon Therapeutics assumed with a Buy at H.C. Wainwright
12/16/20 Wedbush
Replimune Group, Harpoon Therapeutics removed from Best Ideas List at Wedbush
ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
04/05/21 Piper Sandler
Piper Sandler continues to recommend iTeos Therapeutics into data
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
10/07/20 Baird
iTeos Therapeutics initiated with an Outperform at Baird
REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

02/05/21 H.C. Wainwright
Replimune Group price target raised to $60 from $58 at H.C. Wainwright
11/17/20 BTIG
Replimune Group initiated with a Buy at BTIG
11/10/20 H.C. Wainwright
Replimune Group price target raised to $58 from $54 at H.C. Wainwright
RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

03/03/21 SVB Leerink
Revolution Medicines price target raised to $55 from $46 at SVB Leerink
01/29/21 JPMorgan
Revolution Medicines price target raised to $44 from $33 at JPMorgan
10/26/20 H.C. Wainwright
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

03/26/21 H.C. Wainwright
Zentalis price target raised to $65 from $43 at H.C. Wainwright
01/19/21 Wedbush
Zentalis initiated with an Outperform at Wedbush
09/28/20 Cantor Fitzgerald
Cantor starts 'underappreciated' Zentalis with Overweight, $44 target
09/28/20 Cantor Fitzgerald
Zentalis initiated with an Overweight at Cantor Fitzgerald
IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

03/02/21 Jefferies
Immunocore initiated with a Buy at Jefferies
03/02/21 JPMorgan
Immunocore initiated with an Overweight at JPMorgan
03/02/21 Goldman Sachs
Immunocore initiated with a Neutral at Goldman Sachs
PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

10/20/20 Evercore ISI
PMV Pharmaceuticals initiated with an Outperform at Evercore ISI
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 Cowen
PMV Pharmaceuticals initiated with an Outperform at Cowen
ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
03/30/21 Cantor Fitzgerald
Arvinas price target raised to $140 from $121 at Cantor Fitzgerald
03/01/21 Roth Capital
Arvinas reaffirmed 'major catalysts' for 2021, says Roth Capital
01/19/21 Oppenheimer
Arvinas price target raised to $100 from $80 at Oppenheimer
IOVA Iovance Biotherapeutics
$30.17 /

-1.12 (-3.58%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
ADXS Advaxis
/

+

AGEN Agenus
$2.78 /

-0.01 (-0.36%)

09/22/20 B. Riley
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
09/18/20 Jefferies
Agenus price target raised to $8 from $5 at Jefferies
BPTH Bio-Path
$6.79 /

-0.13 (-1.88%)

04/06/21 H.C. Wainwright
Bio-Path price target raised to $12 from $10 at H.C. Wainwright
04/05/21 Roth Capital
Bio-Path triple regimen data 'highly favorable,' says Roth Capital
03/11/21 Roth Capital
Bio-Path Holdings initiated with a Buy at Roth Capital
11/16/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $10 from $12 at H.C. Wainwright
INCY Incyte
$79.97 /

-0.91 (-1.13%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
IMAB I-MAB
$51.50 /

-1.34 (-2.54%)

03/15/21 Needham
I-MAB initiated with a Buy at Needham
03/03/21 H.C. Wainwright
I-MAB price target raised to $75 from $55 at H.C. Wainwright
02/25/21
Fly Intel: Top five analyst initiations
02/25/21 Piper Sandler
I-MAB initiated with an Overweight at Piper Sandler
MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
12/02/20 Stifel
Mersana Therapeutics initiated with a Buy at Stifel
09/29/20 JPMorgan
Mersana Therapeutics resumed with a Neutral at JPMorgan
RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

03/15/21 H.C. Wainwright
Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright
10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
PPBT Purple Biotech
$4.31 /

+0.035 (+0.82%)

12/31/20 H.C. Wainwright
H.C. Wainwright reiterates Buy, $25 price target on Purple Biotech
SONN Sonnet BioTherapeutics
$2.24 /

-0.05 (-2.18%)

09/04/20 Chardan
Sonnet BioTherapeutics price target raised to $8 from $7 at Chardan
06/05/20 Chardan
Sonnet BioTherapeutics initiated with a Buy at Chardan
STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
11/03/20 Needham
Shattuck Labs initiated with a Buy at Needham
11/03/20 Citi
Shattuck Labs initiated with a Buy at Citi
SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

03/10/21 Wedbush
Surface Oncology risk/reward 'highly favorable' into data, says Wedbush
12/18/20 H.C. Wainwright
Surface Oncology price target raised to $15 from $11 at H.C. Wainwright
09/04/20
Fly Intel: Top five analyst initiations
09/04/20 H.C. Wainwright
Surface Oncology initiated with a Buy at H.C. Wainwright
BGNE BeiGene
$308.27 /

-5.8 (-1.85%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
CMPI Checkmate Pharmaceuticals
$10.52 /

+0.14 (+1.35%)

03/19/21 Jefferies
Checkmate Pharmaceuticals price target lowered to $19 from $23 at Jefferies
09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
09/01/20 BofA
BofA starts Checkmate Pharmaceuticals at Neutral ahead of more 'de-risking'
09/01/20 BofA
Checkmate Pharmaceuticals initiated with a Neutral at BofA
BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

IOVA Iovance Biotherapeutics
$30.17 /

-1.12 (-3.58%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

CMPI Checkmate Pharmaceuticals
$10.52 /

+0.14 (+1.35%)

BPTH Bio-Path
$6.79 /

-0.13 (-1.88%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

BGNE BeiGene
$308.27 /

-5.8 (-1.85%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

AGEN Agenus
$2.78 /

-0.01 (-0.36%)

ADXS Advaxis
/

+

  • 17
    Mar
  • 10
    Mar
  • 16
    Feb
  • 09
    Feb
  • 04
    Feb
  • 05
    Feb
  • 20
    Jan
  • 13
    Jan
  • 08
    Jan
  • 07
    Jan
  • 18
    Dec
  • 16
    Dec
  • 02
    Dec
  • 24
    Nov
  • 22
    Oct
  • 09
    Oct
  • 25
    Sep
  • 25
    Sep
  • 07
    Aug
  • 30
    Jul
  • 24
    Jul
  • 09
    Jul
  • 01
    Jul
  • 17
    Jun
  • 09
    Jun
  • 29
    May
  • 29
    May
  • 22
    Apr
INCY Incyte
$79.97 /

-0.91 (-1.13%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

ATNM Actinium Pharmaceuticals
$8.10 /

-0.085 (-1.04%)

ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

PPBT Purple Biotech
$4.31 /

+0.035 (+0.82%)

PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

Friday
On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:39
04/09/21
04/09
16:39
04/09/21
16:39
BA

Boeing

$252.36 /

-2.5 (-0.98%)

, AMZN

Amazon.com

$3,371.40 /

+73.69 (+2.23%)

, CCK

Crown Holdings

$104.85 /

+2.86 (+2.80%)

, AZN

AstraZeneca

$49.95 /

+0.465 (+0.94%)

, JNJ

Johnson & Johnson

$161.20 /

-1.74 (-1.07%)

, PFE

Pfizer

$36.60 /

+0.64 (+1.78%)

, BNTX

BioNTech

$122.15 /

+7.68 (+6.71%)

, FUBO

FuboTV

$23.30 /

+2.605 (+12.59%)

, LEVI

Levi Strauss

$25.69 /

+0.675 (+2.70%)

, PRVB

Provention Bio

$8.00 /

-1.72 (-17.70%)

, JKS

JinkoSolar

$38.66 /

-0.2 (-0.51%)

The major averages closed…

ShowHide Related Items >><<
PRVB Provention Bio
$8.00 /

-1.72 (-17.70%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LEVI Levi Strauss
$25.69 /

+0.675 (+2.70%)

JNJ Johnson & Johnson
$161.20 /

-1.74 (-1.07%)

JKS JinkoSolar
$38.66 /

-0.2 (-0.51%)

FUBO FuboTV
$23.30 /

+2.605 (+12.59%)

CCK Crown Holdings
$104.85 /

+2.86 (+2.80%)

BNTX BioNTech
$122.15 /

+7.68 (+6.71%)

BA Boeing
$252.36 /

-2.5 (-0.98%)

AZN AstraZeneca
$49.95 /

+0.465 (+0.94%)

AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

BA Boeing
$252.36 /

-2.5 (-0.98%)

04/09/21 Baird
Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
03/29/21 Goldman Sachs
Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
03/19/21 Susquehanna
Boeing price target raised to $300 from $250 at Susquehanna
03/15/21 Morgan Stanley
Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley
AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

04/05/21 Evercore ISI
Amazon.com assumed with an Outperform at Evercore ISI
04/01/21 Wedbush
Microsoft gets another major win within the beltway, says Wedbush
04/01/21 Credit Suisse
Ubiquiti price target lowered to $126 from $157 at Credit Suisse
03/31/21 Wolfe Research
Amazon.com assumed with an Outperform at Wolfe Research
CCK Crown Holdings
$104.85 /

+2.86 (+2.80%)

04/09/21 Goldman Sachs
Crown Holdings initiated with a Neutral at Goldman Sachs
02/11/21 Citi
Crown Holdings price target raised to $125 from $117 at Citi
02/11/21 Barclays
Crown Holdings price target raised to $122 from $103 at Barclays
01/26/21 BMO Capital
Sonoco Products downgraded to Market Perform from Outperform at BMO Capital
AZN AstraZeneca
$49.95 /

+0.465 (+0.94%)

04/07/21 Citi
FibroGen update creates only 'bad optic' for AstraZeneca, says Citi
03/26/21 Piper Sandler
AstraZeneca plan 'opens the door' for Altimmune interest, says Piper Sandler
03/23/21 Societe Generale
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Societe Generale
03/18/21 Deutsche Bank
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Deutsche Bank
JNJ Johnson & Johnson
$161.20 /

-1.74 (-1.07%)

04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
PFE Pfizer
$36.60 /

+0.64 (+1.78%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
BNTX BioNTech
$122.15 /

+7.68 (+6.71%)

01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
FUBO FuboTV
$23.30 /

+2.605 (+12.59%)

04/05/21 Evercore ISI
FuboTV assumed with an Outperform at Evercore ISI
03/29/21 Needham
Needham lays out 'bull case' on 'inexpensive' FuboTV shares
03/09/21 Oppenheimer
FuboTV price target lowered to $35 from $45 at Oppenheimer
03/08/21 Alliance Global Partners
Chicken Soup for the Soul initiated with a Buy at Alliance Global Partners
LEVI Levi Strauss
$25.69 /

+0.675 (+2.70%)

04/09/21 UBS
Levi Strauss price target raised to $34 from $29 at UBS
04/09/21 Citi
Levi Strauss price target raised to $29 from $25 at Citi
01/27/21 Citi
Levi Strauss price target raised to $25 from $19 at Citi
01/07/21 JPMorgan
Levi Strauss price target raised to $21 from $18 at JPMorgan
PRVB Provention Bio
$8.00 /

-1.72 (-17.70%)

04/09/21 SVB Leerink
Provention Bio price target lowered to $16 from $26 at SVB Leerink
04/09/21 RBC Capital
Provention Bio cut to Sector Perform at RBC Capital after teplizumab FDA notice
04/09/21 Cantor Fitzgerald
Provention Bio price target lowered to $25 from $27 at Cantor Fitzgerald
04/09/21 RBC Capital
Provention Bio downgraded to Sector Perform from Outperform at RBC Capital
JKS JinkoSolar
$38.66 /

-0.2 (-0.51%)

02/08/21 Roth Capital
Bill could be 'meaningful positive' for solar stocks, says Roth Capital
01/04/21 Goldman Sachs
JinkoSolar price target raised to $39 from $34 at Goldman Sachs
12/30/20 GLJ Research
GLJ Research keeps Sell on JinkoSolar after chairman, CEO dump shares
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
PRVB Provention Bio
$8.00 /

-1.72 (-17.70%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LEVI Levi Strauss
$25.69 /

+0.675 (+2.70%)

JNJ Johnson & Johnson
$161.20 /

-1.74 (-1.07%)

JKS JinkoSolar
$38.66 /

-0.2 (-0.51%)

FUBO FuboTV
$23.30 /

+2.605 (+12.59%)

CCK Crown Holdings
$104.85 /

+2.86 (+2.80%)

BA Boeing
$252.36 /

-2.5 (-0.98%)

AZN AstraZeneca
$49.95 /

+0.465 (+0.94%)

AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

  • 14
    Jan
  • 30
    Dec
  • 08
    Oct
  • 23
    Jul
  • 18
    Jun
PFE Pfizer
$36.60 /

+0.64 (+1.78%)

JNJ Johnson & Johnson
$161.20 /

-1.74 (-1.07%)

JKS JinkoSolar
$38.66 /

-0.2 (-0.51%)

CCK Crown Holdings
$104.85 /

+2.86 (+2.80%)

BA Boeing
$252.36 /

-2.5 (-0.98%)

AZN AstraZeneca
$49.95 /

+0.465 (+0.94%)

AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

PRVB Provention Bio
$8.00 /

-1.72 (-17.70%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LEVI Levi Strauss
$25.69 /

+0.675 (+2.70%)

JNJ Johnson & Johnson
$161.20 /

-1.74 (-1.07%)

JKS JinkoSolar
$38.66 /

-0.2 (-0.51%)

FUBO FuboTV
$23.30 /

+2.605 (+12.59%)

CCK Crown Holdings
$104.85 /

+2.86 (+2.80%)

BA Boeing
$252.36 /

-2.5 (-0.98%)

AZN AstraZeneca
$49.95 /

+0.465 (+0.94%)

AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

PFE Pfizer
$36.60 /

+0.64 (+1.78%)

LEVI Levi Strauss
$25.69 /

+0.675 (+2.70%)

JNJ Johnson & Johnson
$161.20 /

-1.74 (-1.07%)

JKS JinkoSolar
$38.66 /

-0.2 (-0.51%)

FUBO FuboTV
$23.30 /

+2.605 (+12.59%)

BNTX BioNTech
$122.15 /

+7.68 (+6.71%)

BA Boeing
$252.36 /

-2.5 (-0.98%)

AZN AstraZeneca
$49.95 /

+0.465 (+0.94%)

AMZN Amazon.com
$3,371.40 /

+73.69 (+2.23%)

Hot Stocks
Seagen, Genmab say FDA accepts BLA for tisotumab vedotin for priority review » 16:01
04/09/21
04/09
16:01
04/09/21
16:01
SGEN

Seagen

$142.89 /

-1.6 (-1.11%)

, GMAB

Genmab

$34.19 /

+0.56 (+1.67%)

Seagen (SGEN) and Genmab …

Seagen (SGEN) and Genmab (GMAB) announced that the U.S. Food and Drug Administration has accepted for Priority Review the Biologics License Application seeking accelerated approval for tisotumab vedotin. This BLA requests FDA approval of tisotumab vedotin for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. Under the Prescription Drug User Fee Act, the FDA has set a target action date of October 10, 2021. Tisotumab vedotin is an investigational antibody-drug conjugate directed to tissue factor, a cell-surface protein expressed on multiple solid tumors including cervical cancer, and is associated with tumor growth, angiogenesis, metastasis and poor prognosis. "The FDA's filing of the tisotumab vedotin BLA with Priority Review marks an important step forward for this ADC as a potential treatment for patients with recurrent or metastatic cervical cancer," said Roger Dansey, M.D., Chief Medical Officer at Seagen. "We are collaborating closely with the FDA throughout the review process to make this important therapy available to patients."

ShowHide Related Items >><<
SGEN Seagen
$142.89 /

-1.6 (-1.11%)

GMAB Genmab
$34.19 /

+0.56 (+1.67%)

SGEN Seagen
$142.89 /

-1.6 (-1.11%)

03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
02/16/21 RBC Capital
Seagen price target lowered to $169 from $186 at RBC Capital
02/12/21 Barclays
Seagen price target lowered to $168 from $177 at Barclays
GMAB Genmab
$34.19 /

+0.56 (+1.67%)

03/15/21 DNB Markets
Genmab upgraded to Buy from Sell at DNB Markets
03/09/21 JPMorgan
Genmab price target lowered to DKK 2,350 from DKK 2,600 at JPMorgan
03/09/21 UBS
Genmab price target lowered to DKK 2,500 from DKK 2,630 at UBS
02/25/21 Truist
Genmab price target raised to $47 from $42 at Truist
SGEN Seagen
$142.89 /

-1.6 (-1.11%)

SGEN Seagen
$142.89 /

-1.6 (-1.11%)

Periodicals
J&J in talks for trial in India of COVID-19 vaccine, Business Standard says » 15:00
04/09/21
04/09
15:00
04/09/21
15:00
JNJ

Johnson & Johnson

$160.37 /

-2.57 (-1.58%)

A Johnson & Johnson…

A Johnson & Johnson India spokesperson told the Business Standard: "At J&J, we remain fully focused on bringing a safe and effective Covid-19 vaccine to people around the world, if authorised for use by local health authorities. We are in discussions with the Government of India with the objective of starting clinical study of our Janssen Covid-19 vaccine candidate in India, subject to local regulatory nod." However, at this point, approval to start clinical trials has not been granted to the company, a source close to the development confirmed to Business Standard's Sohini Das. Reference Link

ShowHide Related Items >><<
JNJ Johnson & Johnson
$160.37 /

-2.57 (-1.58%)

JNJ Johnson & Johnson
$160.37 /

-2.57 (-1.58%)

04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
JNJ Johnson & Johnson
$160.37 /

-2.57 (-1.58%)

JNJ Johnson & Johnson
$160.37 /

-2.57 (-1.58%)

JNJ Johnson & Johnson
$160.37 /

-2.57 (-1.58%)

JNJ Johnson & Johnson
$160.37 /

-2.57 (-1.58%)

Hot Stocks
Sanofi acquires Tidal Therapeutics for $160M upfront payment » 13:46
04/09/21
04/09
13:46
04/09/21
13:46
SNY

Sanofi

$50.53 /

+0.16 (+0.32%)

Sanofi said it acquired…

Sanofi said it acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with an mRNA-based approach for in vivo reprogramming of immune cells. "The new technology platform will expand Sanofi's research capabilities in both immuno-oncology and inflammatory diseases, while likely having broad applicability to other disease areas as well." the company said in a statement. Sanofi acquired Tidal Therapeutics for an upfront payment of $160M and up to $310M upon achievement of certain milestones.

ShowHide Related Items >><<
SNY Sanofi
$50.53 /

+0.16 (+0.32%)

SNY Sanofi
$50.53 /

+0.16 (+0.32%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SNY Sanofi
$50.53 /

+0.16 (+0.32%)

SNY Sanofi
$50.53 /

+0.16 (+0.32%)

SNY Sanofi
$50.53 /

+0.16 (+0.32%)

Hot Stocks
Pfizer, BioNTech seek expansion of vaccine EUA to include 12-15 year olds » 12:57
04/09/21
04/09
12:57
04/09/21
12:57
PFE

Pfizer

$36.44 /

+0.475 (+1.32%)

, BNTX

BioNTech

$119.02 /

+4.55 (+3.97%)

Pfizer (PFE) and BioNTech…

Pfizer (PFE) and BioNTech (BNTX) requested amendments to the U.S. Emergency Use Authorization of the Pfizer-BioNTech vaccine to expand the use in adolescents 12 to 15 years of age. The companies plan to request similar rulings by other regulatory authorities worldwide in coming days. "These requests are based on data from the pivotal Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection, which demonstrated 100 percent efficacy and robust antibody response after vaccination with the COVID-19 Vaccine," they said in a statement. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$36.44 /

+0.475 (+1.32%)

BNTX BioNTech
$119.02 /

+4.55 (+3.97%)

PFE Pfizer
$36.44 /

+0.475 (+1.32%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
BNTX BioNTech
$119.02 /

+4.55 (+3.97%)

02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$36.44 /

+0.475 (+1.32%)

  • 23
    Jul
PFE Pfizer
$36.44 /

+0.475 (+1.32%)

PFE Pfizer
$36.44 /

+0.475 (+1.32%)

PFE Pfizer
$36.44 /

+0.475 (+1.32%)

BNTX BioNTech
$119.02 /

+4.55 (+3.97%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:54
04/09/21
04/09
12:54
04/09/21
12:54
BA

Boeing

$251.71 /

-3.15 (-1.24%)

, AMZN

Amazon.com

$3,352.25 /

+54.54 (+1.65%)

, CCK

Crown Holdings

$104.06 /

+2.07 (+2.03%)

, AZN

AstraZeneca

$49.80 /

+0.315 (+0.64%)

, JNJ

Johnson & Johnson

$159.95 /

-2.99 (-1.84%)

, AFMD

Affimed

$9.73 /

+1.86 (+23.63%)

, LEVI

Levi Strauss

$25.48 /

+0.465 (+1.86%)

, PRVB

Provention Bio

$8.20 /

-1.52 (-15.64%)

, JKS

JinkoSolar

$38.04 /

-0.82 (-2.11%)

The major averages are…

ShowHide Related Items >><<
PRVB Provention Bio
$8.20 /

-1.52 (-15.64%)

LEVI Levi Strauss
$25.48 /

+0.465 (+1.86%)

JNJ Johnson & Johnson
$159.95 /

-2.99 (-1.84%)

JKS JinkoSolar
$38.04 /

-0.82 (-2.11%)

CCK Crown Holdings
$104.06 /

+2.07 (+2.03%)

BA Boeing
$251.71 /

-3.15 (-1.24%)

AZN AstraZeneca
$49.80 /

+0.315 (+0.64%)

AMZN Amazon.com
$3,352.25 /

+54.54 (+1.65%)

AFMD Affimed
$9.73 /

+1.86 (+23.63%)

BA Boeing
$251.71 /

-3.15 (-1.24%)

04/09/21 Baird
Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
03/29/21 Goldman Sachs
Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
03/19/21 Susquehanna
Boeing price target raised to $300 from $250 at Susquehanna
03/15/21 Morgan Stanley
Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley
AMZN Amazon.com
$3,352.25 /

+54.54 (+1.65%)

04/05/21 Evercore ISI
Amazon.com assumed with an Outperform at Evercore ISI
04/01/21 Wedbush
Microsoft gets another major win within the beltway, says Wedbush
04/01/21 Credit Suisse
Ubiquiti price target lowered to $126 from $157 at Credit Suisse
03/31/21 Wolfe Research
Amazon.com assumed with an Outperform at Wolfe Research
CCK Crown Holdings
$104.06 /

+2.07 (+2.03%)

04/09/21 Goldman Sachs
Crown Holdings initiated with a Neutral at Goldman Sachs
02/11/21 Citi
Crown Holdings price target raised to $125 from $117 at Citi
02/11/21 Barclays
Crown Holdings price target raised to $122 from $103 at Barclays
01/26/21 BMO Capital
Sonoco Products downgraded to Market Perform from Outperform at BMO Capital
AZN AstraZeneca
$49.80 /

+0.315 (+0.64%)

04/07/21 Citi
FibroGen update creates only 'bad optic' for AstraZeneca, says Citi
03/26/21 Piper Sandler
AstraZeneca plan 'opens the door' for Altimmune interest, says Piper Sandler
03/23/21 Societe Generale
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Societe Generale
03/18/21 Deutsche Bank
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Deutsche Bank
JNJ Johnson & Johnson
$159.95 /

-2.99 (-1.84%)

04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
AFMD Affimed
$9.73 /

+1.86 (+23.63%)

03/30/21 Credit Suisse
Affimed N.V. initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Affimed N.V. initiated with an Outperform at Credit Suisse
03/24/21 Wells Fargo
Affimed N.V. price target raised to $15 from $10 at Wells Fargo
03/10/21 BMO Capital
BMO Capital ups Affimed N.V. target to $12 following AFM13 interim analysis
LEVI Levi Strauss
$25.48 /

+0.465 (+1.86%)

04/09/21 UBS
Levi Strauss price target raised to $34 from $29 at UBS
04/09/21 Citi
Levi Strauss price target raised to $29 from $25 at Citi
01/27/21 Citi
Levi Strauss price target raised to $25 from $19 at Citi
01/07/21 JPMorgan
Levi Strauss price target raised to $21 from $18 at JPMorgan
PRVB Provention Bio
$8.20 /

-1.52 (-15.64%)

04/09/21 SVB Leerink
Provention Bio price target lowered to $16 from $26 at SVB Leerink
04/09/21 RBC Capital
Provention Bio cut to Sector Perform at RBC Capital after teplizumab FDA notice
04/09/21 Cantor Fitzgerald
Provention Bio price target lowered to $25 from $27 at Cantor Fitzgerald
04/09/21 RBC Capital
Provention Bio downgraded to Sector Perform from Outperform at RBC Capital
JKS JinkoSolar
$38.04 /

-0.82 (-2.11%)

02/08/21 Roth Capital
Bill could be 'meaningful positive' for solar stocks, says Roth Capital
01/04/21 Goldman Sachs
JinkoSolar price target raised to $39 from $34 at Goldman Sachs
12/30/20 GLJ Research
GLJ Research keeps Sell on JinkoSolar after chairman, CEO dump shares
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
PRVB Provention Bio
$8.20 /

-1.52 (-15.64%)

LEVI Levi Strauss
$25.48 /

+0.465 (+1.86%)

JNJ Johnson & Johnson
$159.95 /

-2.99 (-1.84%)

JKS JinkoSolar
$38.04 /

-0.82 (-2.11%)

CCK Crown Holdings
$104.06 /

+2.07 (+2.03%)

BA Boeing
$251.71 /

-3.15 (-1.24%)

AZN AstraZeneca
$49.80 /

+0.315 (+0.64%)

AMZN Amazon.com
$3,352.25 /

+54.54 (+1.65%)

  • 14
    Jan
  • 13
    Jan
  • 18
    Jun
JNJ Johnson & Johnson
$159.95 /

-2.99 (-1.84%)

JKS JinkoSolar
$38.04 /

-0.82 (-2.11%)

CCK Crown Holdings
$104.06 /

+2.07 (+2.03%)

BA Boeing
$251.71 /

-3.15 (-1.24%)

AZN AstraZeneca
$49.80 /

+0.315 (+0.64%)

AMZN Amazon.com
$3,352.25 /

+54.54 (+1.65%)

PRVB Provention Bio
$8.20 /

-1.52 (-15.64%)

LEVI Levi Strauss
$25.48 /

+0.465 (+1.86%)

JNJ Johnson & Johnson
$159.95 /

-2.99 (-1.84%)

JKS JinkoSolar
$38.04 /

-0.82 (-2.11%)

CCK Crown Holdings
$104.06 /

+2.07 (+2.03%)

BA Boeing
$251.71 /

-3.15 (-1.24%)

AZN AstraZeneca
$49.80 /

+0.315 (+0.64%)

AMZN Amazon.com
$3,352.25 /

+54.54 (+1.65%)

AFMD Affimed
$9.73 /

+1.86 (+23.63%)

LEVI Levi Strauss
$25.48 /

+0.465 (+1.86%)

JNJ Johnson & Johnson
$159.95 /

-2.99 (-1.84%)

JKS JinkoSolar
$38.04 /

-0.82 (-2.11%)

BA Boeing
$251.71 /

-3.15 (-1.24%)

AZN AstraZeneca
$49.80 /

+0.315 (+0.64%)

AMZN Amazon.com
$3,352.25 /

+54.54 (+1.65%)

Periodicals
AstraZeneca slashes vaccine deliveries to EU by 49%, FT reports » 11:29
04/09/21
04/09
11:29
04/09/21
11:29
AZN

AstraZeneca

$49.85 /

+0.365 (+0.74%)

AstraZeneca has reduced…

AstraZeneca has reduced the number of COVID-19 vaccine doses it will deliver to EU nations this week by nearly half, the Finiancial Times' Donato Paolo Mancini, Hannah Kuchler, and Michael Peel reports. The company now anticipates delivering roughly 1.3M shots to the EU's 27 nations, plus Iceland and Norway, down from the 2.6M target it established last month, the authors say, citing documents seen by the FT. The reduction is equivalent to a 49% slashing and is evenly distributed across member states, the authors note. Reference Link

ShowHide Related Items >><<
AZN AstraZeneca
$49.85 /

+0.365 (+0.74%)

AZN AstraZeneca
$49.85 /

+0.365 (+0.74%)

04/07/21 Citi
FibroGen update creates only 'bad optic' for AstraZeneca, says Citi
03/26/21 Piper Sandler
AstraZeneca plan 'opens the door' for Altimmune interest, says Piper Sandler
03/23/21 Societe Generale
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Societe Generale
03/18/21 Deutsche Bank
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Deutsche Bank
AZN AstraZeneca
$49.85 /

+0.365 (+0.74%)

AZN AstraZeneca
$49.85 /

+0.365 (+0.74%)

AZN AstraZeneca
$49.85 /

+0.365 (+0.74%)

AZN AstraZeneca
$49.85 /

+0.365 (+0.74%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.